Bookmark this page — the only place tracking real acceptance speed, FWCI and field-normalized citation data for this journal.

Journal decision profile

Science Immunology

Immunology and Microbiology · Medicine
American Association for the Advancement of ScienceUnited StatespISSN 2470-9468eISSN 2470-9468
Checking system sharing availability.Visit homepage
15.22026 metrics scoreOpenAlex · CC0
median speedinsufficient public data
$—publishing cost*verify with journal
Journal Metrics Score
i
Journal Metrics ScoreThe visible value is the 2026Journal Metrics Score: citations in the most recent complete year to the journal's works from the two prior years, divided by the number of those works — from OpenAlex open data (CC0).
2026
15.2

Journal Metrics Score 2026 · 20212024 window citedness 17.17.

Speed
i
SpeedMedian calendar days from manuscript received to accepted. It includes revision time and is not the journal's time to first decision.
PUBMED
Not available

Insufficient public received and accepted dates.

APC / cost*
i
APC / cost*Costs are indicative and may exclude taxes, waivers, society discounts, or article-type charges. Always verify the journal's official website.
VERIFY
Not available

No reliable journal-level APC is cached. Cost is excluded from scoring.

At a glance

Journal decision profile

A visual summary for comparison—not a single black-box star rating.

Relative profile

Metrics ScoreThe 2026 Journal Metrics Score normalized within a comparable journal cohort.iSource outputLifetime journal-wide output rank among OpenAlex sources associated with the leading topic.iTop 10% shareShare of recent works in the field-normalized global top 10%.iMedian FWCITypical field-weighted citation impact, where 1.0 is the world expectation.iOutput volumeRecent publication volume relative to comparable journals.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 Journal Metrics Score, normalized within a comparable journal cohort for this preview.
15.22026 · OPENALEX
Source output rank
i
Source output rankLifetime journal-wide output rank among OpenAlex sources associated with the journal’s leading topic.
#367 / 1,387LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersRecent works in the global top 10% after normalization by work type, year, and subfield.
62.6%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactMedian FWCI, where 1.0 is the expected citation level for comparable work.
3.92MEDIAN FWCI
Review speed
i
Review speedMedian submission-to-acceptance time from qualified PubMed records.
NOT AVAILABLE
Recent output
i
Recent outputAverage annual publication volume across the complete analysis window.
175 / yr2021–2024 AVG
Cost efficiency
i
Cost efficiencyNo score is assigned without a reliable journal-level cost.
NOT SCORED
Field-normalized top 10% share62.6%

436 of 696 works · same type, year & subfield

Field-normalized top 1% share12.8%

89 works · same type, year & subfield

Median FWCI3.92×

Above field-year expectation

Source output rank#367

of 1,387 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 3.92, so its typical recent paper runs about 292% above its field benchmark.

What does Top 10% Share mean?

62.6% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Submission to acceptance time (publication speed)

There are not enough complete public received and accepted dates to show a reliable median. It includes revisions and is not the journal's time to first decision.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 20162025

382016
1012017
1032018
1192019
1412020
1822021
1942022
1512023
1712024
1552025

Recent work-type mix

696 OpenAlex works · 20212024

Article94.5%
Editorial3.9%
Erratum1.6%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works
COVID-19CD8-Positive T-LymphocytesNeoplasmsB-LymphocytesSARS-CoV-2Immunity, InnateMice, Inbred C57BLT-LymphocytesT-Lymphocytes, Regulatory

Leading OpenAlex topics

20212024 works
Immune Cell Function and Interaction112
SARS-CoV-2 and COVID-19 Research67
T-cell and B-cell Immunology60
IL-33, ST2, and ILC Pathways39
Immunotherapy and Immune Responses33
CAR-T cell therapy research29
Cancer Immunotherapy and Biomarkers24
Immune cells in cancer19
interferon and immune responses19
Inflammasome and immune disorders16
Methodology: OpenAlex snapshot 2026-08-09. FWCI, percentile badges, topics, and type mix use 696 works published 20212024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
ImmunologyQ1
OncologyQ1
Q1
Subfield Quartile
B1
CAS Block

Ranking and source check

#7
of 469 Immunology & Microbiology field journals
#7
among Q1 Immunology & Microbiology journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

Considering submitting to Science Immunology?

See if your manuscript fits this journal's recent focus before you commit to a shortlist.

Match my manuscript →

Journal Details

Total Articles
1,443
H-Index
164
Open Access
Hybrid (53% OA)
Subject Areas
ImmunologyImmunologyImmunologyOncology
Back to Search